Vivos Therapeutics (VVOS) Q2 2024 Earnings

14MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-3.05
-2.07
-1.08
-0.1

Details

Expected EPS
-1.175
Actual EPS
-1.63
Surprise EPS
-0.45
Surprise Percent
+38.72%

Description

Vivos Therapeutics (VVOS) has reported earnings of -1.63 per share for Q2 2024.

0 Comments

Share your thoughts